Found 96 matching trials
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer PHASE2 Researchers conducting this study hope to learn about the safety and effect...
Show More Location
University of Chicago Comprehensive Cancer Center
Learn More & Join Trial
Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer PHASE2 This research study is evaluating a drug called enzalutamide in combination...
Show More Location
Hospital Ramón y Cajal
Learn More & Join Trial
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer PHASE1 The purpose of this study is to determine the safety, tolerability and phar...
Show More Location
ATTN-Research Pharmacist
Learn More & Join Trial
Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer PHASE1 This Phase I, open-label, dose-finding, multicenter study is designed to de...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) PHASE2 The primary objective in this study is to evaluate bone scan response at We...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer PHASE1 This is a global, multi-center, open-label, randomized phase 1b/2, active-c...
Show More Location
Genesis Healthcare Partners
Learn More & Join Trial
Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) PHASE2 This is a multicenter, open-label, randomized, two-arm, phase II clinical t...
Show More Location
Institut Català d'Oncologia Badalona
Learn More & Join Trial
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) PHASE2 Single-arm, single site, open label study of the effects of parenteral test...
Show More Location
Sibley Memorial Hospital
Learn More & Join Trial
Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent PHASE3 To demonstrate the efficacy of VERU-111 (Sabizabulin) in the treatment of m...
Show More Location
Alaska Oncology and Hematology, LLC.
Learn More & Join Trial
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer PHASE4 The objective of this study was to compare the efficacy and safety of the c...
Show More Learn More & Join Trial